David A. Santos

EVP, Chief Commercial Officer, RIGEL PHARMACEUTICALS INC.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Sep 1, 2026Shares withheld for tax 874 shares at $47.50 of RIGEL PHARMACEUTICALS INC²
Jun 1, 2026Shares withheld for tax 874 shares at $29.86 of RIGEL PHARMACEUTICALS INC³
Feb 17, 2026Granted 19,430 shares of RIGEL PHARMACEUTICALS INC⁴
Feb 10, 2026Shares withheld for tax 3,546 shares at $34.62 of RIGEL PHARMACEUTICALS INC⁵
Feb 2, 2026Shares withheld for tax 5,718 shares at $36.01 of RIGEL PHARMACEUTICALS INC⁶
Feb 5, 2025Sold 1,796 shares at $21.93 of RIGEL PHARMACEUTICALS INC⁷
Feb 4, 2025Sold 2,125 shares at $20.92 of RIGEL PHARMACEUTICALS INC⁷
Jan 29, 2025Granted 19,717 shares of RIGEL PHARMACEUTICALS INC⁸
Feb 5, 2024Sold 8,918 shares at $1.14 of RIGEL PHARMACEUTICALS INC⁹
Feb 2, 2024Sold 5,601 shares at $1.13 of RIGEL PHARMACEUTICALS INC⁹
Jan 23, 2024Granted 209,000 shares of RIGEL PHARMACEUTICALS INC¹⁰
Feb 2, 2023Sold 5,388 shares at $1.66 of RIGEL PHARMACEUTICALS INC¹¹
Jan 26, 2023Granted 80,000 shares of RIGEL PHARMACEUTICALS INC¹²
Jan 24, 2022Granted 50,000 shares of RIGEL PHARMACEUTICALS INC¹³

The numbers on this page point here. Each one links to the record it came from.